NCT01006694

Brief Summary

Trained para-professional health care workers will implement a stepped-care model of depression care in commune health stations in Vietnam.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
473

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2010

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 2, 2009

Completed
1 day until next milestone

First Posted

Study publicly available on registry

November 3, 2009

Completed
4 months until next milestone

Study Start

First participant enrolled

March 1, 2010

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2012

Completed
Last Updated

March 5, 2015

Status Verified

March 1, 2015

Enrollment Period

2.2 years

First QC Date

November 2, 2009

Last Update Submit

March 4, 2015

Conditions

Keywords

depressioncollaborative careVietnambehavioral activation

Outcome Measures

Primary Outcomes (1)

  • Change across time (random effects slope) in depressive symptoms, as assessed by the PHQ-9 questionnaire

    The PHQ-9 (Patient Health Questionnaire-9) assesses depressive symptoms, over the last two weeks. It is assessed at 0, 6, 12, 24 weeks. The outcome target is the linear and quadratic change slopes across these 4 time points.

    0, 6, 12, 24 weeks

Secondary Outcomes (6)

  • Change across time (random effects slope) in anxiety symptoms, as assessed by the GAD-7 questionnaire

    0, 6, 12, 24 weeks

  • Change across time (random effects slope) in physical health, as assessed by the SF-12 questionnaire, Physical Health subscale

    0, 6, 12, 24 weeks

  • Change across time (random effects slope) in mental health, as assessed by the SF-12 questionnaire, Mental Health subscale

    0, 6, 12, 24 weeks

  • Change across time (random effects slope) in behavioral activation skills and behaviors, as assessed by the BADS questionnaire.

    0, 6, 12, 24 weeks

  • "Substantial improvement" in depressive symptoms, as assessed by the PHQ-9

    6, 12, 24 weeks

  • +1 more secondary outcomes

Study Arms (2)

Guideline Antidepressant Medication

ACTIVE COMPARATOR

Guideline Antidepressant Medication, following the VN National Mental Health plan.

Drug: Guideline Antidepressant Medication

Behavioral Activation + Medication

EXPERIMENTAL

Psychoeducation, behavioral activation therapy, and medication delivered within a collaborative care model.

Other: Behavioral Activation + Medication

Interventions

Psychoeducation, behavioral activation therapy, and medication delivered within a collaborative care model.

Also known as: BA + SSRI
Behavioral Activation + Medication

Guideline Antidepressant Medication, following the VN National Mental Health plan.

Guideline Antidepressant Medication

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age \>=18
  • Depression Diagnosis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Khanh Hoa Provincial Hospital

Nha Trang, Khanh Hoa, Vietnam

Location

Danang Psychiatric Hospital

Da Nang, Vietnam

Location

MeSH Terms

Conditions

Depression

Interventions

Dosage FormsSelective Serotonin Reuptake Inhibitors

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehavior

Intervention Hierarchy (Ancestors)

Pharmaceutical PreparationsTechnology, PharmaceuticalInvestigative TechniquesNeurotransmitter Uptake InhibitorsMembrane Transport ModulatorsMolecular Mechanisms of Pharmacological ActionPharmacologic ActionsChemical Actions and UsesNeurotransmitter AgentsSerotonin AgentsPhysiological Effects of Drugs

Study Officials

  • victoria ngo, phd

    RAND

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

November 2, 2009

First Posted

November 3, 2009

Study Start

March 1, 2010

Primary Completion

May 1, 2012

Study Completion

May 1, 2012

Last Updated

March 5, 2015

Record last verified: 2015-03

Locations